An important question relating to the role of a proinflammatory microenvironment in improving the clinical course of CRC is whether CD16−/CD56+ NK cells are involved in bidirectional crosstalk with CRC cells and CD8+ T-cells. The gene discussed is NCAM1; the disease is colorectal carcinoma.